Publications by authors named "A K Cordeiro"

Intranasal drug administration offers a promising strategy for delivering combination antiretroviral therapy (cART) directly to the central nervous system to treat NeuroAIDS, leveraging the nose-to-brain route to bypass the blood-brain barrier. However, challenges such as enzymatic degradation in the nasal mucosa, low permeability, and mucociliary clearance within the nasal cavity must first be addressed to make this route feasible. To overcome these barriers, this study developed solid lipid nanoparticles (SLNs) with varying PEGylation levels (0 %, 5 %, 10 %, and 15 % w/w of PEGylated lipid), co-encapsulated with Elvitegravir (EVG) and Atazanavir (ATZ) as an integrase and protease inhibitor, respectively.

View Article and Find Full Text PDF

The use of dissolving microneedle arrays (dMNA) for intradermal and transdermal drug delivery has been a growing trend in the field for the past decades. However, a lack of specific regulatory standards still hinders their clinical development and translation to market. It is also well-known that dMNA composition significantly impacts their performance, with each new formulation potentially presenting a challenge for developers, manufacturers and regulatory agencies.

View Article and Find Full Text PDF

Background/objectives: Myosteatosis has been associated with sarcopenia, and increased mortality risk in patients on hemodialysis. We aimed to explore the associations between myosteatosis, as assessed by computed tomography (CT), with demographic parameters, body composition metrics, muscle strength, metabolic parameters and mortality in patients with chronic kidney disease (CKD).

Subjects/methods: We enrolled 216 patients (age 60.

View Article and Find Full Text PDF

Objective: To systematically review the effects of recruitment maneuvers on patients with acute respiratory distress syndrome.

Methods: This systematic review and meta-analysis using the PICO methodology with keywords (respiratory distress syndrome, recruitment maneuvers, lung recruitment, acute respiratory distress syndrome, alveolar recruitment, and adult acute respiratory distress syndrome). Studies involving patients >18 years, regardless of sex, with acute respiratory distress syndrome, mechanically ventilated for at least 24 h, published in English, Portuguese, and Spanish, with no year restrictions, were included.

View Article and Find Full Text PDF
Article Synopsis
  • Trypanosoma cruzi is the protozoan responsible for Chagas Disease, which lacks effective diagnostic and treatment options, prompting a study of its metabolism and adaptation to different environments.
  • Recent research shows T. cruzi can utilize various carbon sources, including threonine, during growth and starvation, leading to the discovery of a pathway for threonine degradation.
  • The study identified a compound (TCMDC-143160) that inhibits a key enzyme (TcTDH) involved in threonine catabolism, providing insights into potential therapeutic targets for Chagas Disease.
View Article and Find Full Text PDF